| Enhancer ID: | E_01_0704 |
| Species: | human |
| Position : | chr8:127397745-127399745 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Oophoroma |
| Pubmed ID: | 29435081 |
| Enhancer experiment: | Total RNA extraction,RT?qPCR,Small interfering RNAs (siRNAs) and transfection,Monolayer wound healing assay,Transwell invasion assay,Western blot,TOP?FLASH luciferase assay |
| Enhancer experiment description: | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
| Target gene : | CCAT2 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
| TF name : | -- |
| TF experiment: | Total RNA extraction,RT?qPCR,Small interfering RNAs (siRNAs) and transfection,Monolayer wound healing assay,Transwell invasion assay,Western blot,TOP?FLASH luciferase assay |
| TF experiment description: | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
| Enhancer function : | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|